Mesoblast | MSB - Net Income

Stock Price
2.35
Daily Change
0.05 2.17%
Monthly
-11.32%
Yearly
-4.47%
Q1 Forecast
2.36

Mesoblast reported $-54.21M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Avita Medical AUD -9.92M 1.67M Jun/2025
Clinuvel Pharmaceuticals AUD 24.7M 13.76M Jun/2024
Cochlear AUD 91.9M 113.2M Jun/2025
CSL USD 497.5M 1.51B Jun/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
Paradigm Biopharmaceuticals AUD -6.42M 495.95K Jun/2025
PYC Therapeutics AUD -12.37M 13.2M Jun/2025
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Starpharma Holdings AUD -2.3M 3.09M Jun/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025